Prealbumin (Transthyretin)
Liver Tissue stained with Anti-Prealbumin using AEC Chromogen
| Clone | : | EP2929Y |
| Isotype | : | IgG |
| Immunogen | : | A synthetic peptide corresponding to residues on the C-terminus of the human Prealbumin was used as an immunogen |
| Source | : | Rabbit |
| Specificity | : | Prealbumin |
| Protocol | : | 30 min @ RT |
| Tissue type | : | FFPE |
| Control tissue | : | Liver Tissue |
| Pretreatment | : | EZ-AR™ 2 |
| Intended Use | : | IVD |
Transthyretin/Prealbumin/TTR is a hormone-binding protein that participates in the plasma transport of both thyroxine and retinol (vitamin A). Transthyretin concentrations are disproportionately high in human ventricular CSF. It is reported to be either selectively transported across or synthesized within the blood-CSF barrier. Over 80 different disease-causing mutations in transthyretin have been reported. The vast majority is inherited in an autosomal dominant manner and is related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart. A small portion of transthyretin mutations are apparently non-amyloidogenic. The human amyloid disorders, familial amyloid polyneuropathy, familial amyloid cardiomyopathy and senile systemic amyloidosis, are caused by insoluble transthyretin fibrils. Transthyretin has a structural complementarity to double-helical DNA, where the proposed binding site is composed of two symmetry-related beta-sheets containing a pair of helically disposed arms.
